NeuroTechnology Investors
Overview
NeuroTech-NL is a public-private partnership in the Netherlands around neurotechnology including implants, brain stimulation, and artificial intelligence. Our vision is a world where the deaf can hear…
Investment Focus
- Innovative medical technologies
- Experienced management teams
- Scalable business models
- Strong intellectual property portfolios
- Clear regulatory pathways
- Potential for significant patient impact
- Alignment with healthcare industry trends
- Ability to attract follow-on funding
- Commitment to ethical practices
- Demonstrated market need
- Competitive differentiation
- Sustainable business practices
- Global market potential
- Clinical validation
- Regulatory compliance
Portfolio Companies
Reach NeuroTechnology Investors directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about NeuroTechnology Investors
What sectors does NeuroTechnology Investors invest in?
NeuroTechnology Investors invests in Healthcare, Artificial Intelligence, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Amsterdam, Netherlands. NeuroTechnology Investors is listed as a venture capital in the ConnectSafely investor database.
What stage does NeuroTechnology Investors invest at?
NeuroTechnology Investors backs companies at Seed, Early Stage, Series A, Series B, Growth and Late Stage, writing cheques of 1M - 50M.
Which regions does NeuroTechnology Investors invest in?
NeuroTechnology Investors invests across United States.
What companies has NeuroTechnology Investors invested in?
NeuroTechnology Investors's portfolio includes Synchron and Presidio Medical.
How do I contact NeuroTechnology Investors?
NeuroTechnology Investors's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
